India's largest biopharmaceutical company Biocon will expand its presence in Hyderabad while its subsidiary Syngene will set up a research and developmentm an official statement said on Friday.
The expansion and new facility are expected to create 1,500 jobs, the company announced on the sidelines of 15th BioAsia.
Biocon will increase its presence in APIs (Active Pharmaceutical Ingredients)/ Intermediates to add 500 new jobs, said a statement from the office of Telangana's Industry Minister K. T. Rama Rao, who met Biocon MD Kiran Mazumdar Shaw.
The R&D lab will come up in Genome Valley to generate another 1,000 high-tech jobs.
The minister gave an overview of the infrastructure that the state government is developing including Pharma City, Medical Devices Park and Genome Valley Phase 2.
Earlier, a business delegation headed by Thailand's Deputy Commerce Minister Chutima Bunyapraphasara,met Ramo Rao, who explained about the state's proactive business environment and how the state has ranked number one in Ease of Doing Business index. He gave an overview of various priority sectors like pharma, life sciences, aviation, food processing etc.
During a meeting with Italian Consul General in Mumbai Stefania Costanza, the minister said that the startup state of Telangana has become a role model state in attracting investments.
Rama Rao also met Terri Bresenham, CEO & President, Sustainable Healthcare Division, GE, who expressed interest to collaborate with Telangana Academy of Skill & Knowledge in healthcare skilling.
--IANS
ms/vd
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
